Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14+R) in high-risk diffuse large cell lymphoma

Author: Avilés Agustin   Nambo María   Neri Natividad   Cleto Sergio   Castañeda Claudia   Huerta-Guzmàn Judith   Murillo Edgar   Contreras Margarita   Talavera Alejandra   González Martha  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.24, Iss.1, 2007-01, pp. : 85-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content